OXT and craniopharyngioma: While no significant differences were found between baseline salivary oxytocin concentrations in patients and controls, the findings of this review suggest that patients with craniopharyngioma may present a deficit in oxytocin secretion in response to a stressor, and that hypothalamic damage poses a likely moderator of the severity of this dysregulation.